PubRank

A novel combination strategy for effectively targeting cancer stem-like cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28529324)

Published in Immunol Cell Biol on May 22, 2017

Authors

Paul A Beavis1,2, Emma V Petley1,2, Phillip K Darcy1,2,3,4

Author Affiliations

1: Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
2: Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
3: Department of Pathology, University of Melbourne, Parkville, Victoria, Australia.
4: Department of Immunology, Monash University, Clayton, Victoria, Australia.

Articles cited by this ↗

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. N Engl J Med (2016) 4.33

Immune Checkpoint Blockade in Cancer Therapy. J Clin Oncol (2015) 4.25

How tumours escape mass destruction. Oncogene (2008) 1.82

γδ T cells in cancer. Nat Rev Immunol (2015) 1.39

Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines. Clin Cancer Res (2011) 1.04

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. Cancer Discov (2016) 0.98